Sage Therapeutics Inc (SAGE)
180.26
-7.15 -3.82%
NASDAQ
Jul 16, 16:58
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -9.74 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -461.69M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -35.14K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 9.220B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | -- |
| PE Ratio (TTM) | -- |
| Price to Book Value | 6.987 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -151.19M |
| Return on Equity (TTM) | Upgrade |
View All SAGE News
News
-
WireHeadlineTime (ET)
-
Yahoo07/16 08:04
-
Business Wire07/11 06:30
-
Yahoo07/10 13:14
-
SA Breaking News07/09 12:44
-
Yahoo07/09 08:04
-
Yahoo07/09 06:40
-
Business Wire07/03 06:30
-
SA Breaking News07/01 09:43
-
Business Wire06/27 06:30
-
SA Breaking News06/26 10:48
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 11/06/2019 08:00 EST | Misc | Sage Therapeutics Inc Third Quarter Earnings Conference Call in 2019 |
| 11/06/2019 | Earnings | Sage Therapeutics Inc Third Quarter Earnings in 2019 Release |
| 08/06/2019 08:00 EDT | Misc | Sage Therapeutics Inc Second Quarter Earnings Conference Call in 2019 |
| 08/06/2019 | Earnings | Sage Therapeutics Inc Second Quarter Earnings in 2019 Release |
| 06/05/2019 09:00 EDT | Misc | Sage Therapeutics Inc Annual General Meeting in 2018 |
| 05/02/2019 08:00 EDT | Misc | Sage Therapeutics Inc First Quarter Earnings Conference Call in 2019 |
| 05/02/2019 | Earnings | Sage Therapeutics Inc First Quarter Earnings in 2019 Release |
| 02/19/2019 08:00 EST | Misc | Sage Therapeutics Inc Fourth Quarter Earnings Conference Call in 2018 |
| 02/19/2019 | Earnings | Sage Therapeutics Inc Fourth Quarter Earnings in 2018 Release |
| 02/19/2019 | Misc | Sage Therapeutics Inc Annual Report in 2018 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.sagerx.com
- Investor Relations URL: http://investor.sagerx.com/
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Aug. 06, 2019
- Last Earnings Release: May. 02, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-547, it is in Phase 3 clinical trials for super-refractory status epilepticus; and the SAGE-217 program which is in Phase 2 clinical trials for post-partum depression, essential tremor, Parkinson's disease and major depressive disorder. The company is also developing several other compounds for treatment that is in the early stage of development.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 180.26 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| BTEC | Principal Healthcare Innovators ETF | 2.54% |
| THISX | T. Rowe Price Health Sciences I | 2.43% |
| FBIOX | Fidelity® Select Biotechnology | 2.20% |
| XBI | SPDR® S&P Biotech ETF | 1.48% |
| IBB | iShares Nasdaq Biotechnology ETF | 1.33% |
| HFMRX | Hartford MidCap R3 | 1.25% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 1.12% |
| FGCKX | Fidelity® Growth Company K | 0.98% |
| VISVX | Vanguard Small Cap Value Index Inv | 0.50% |
| VBR | Vanguard Small-Cap Value ETF | 0.48% |
| NAESX | Vanguard Small Cap Index Inv | 0.26% |
| VB | Vanguard Small-Cap ETF | 0.25% |
Excel Add-In Codes
- Name: =YCI("SAGE","name")
- Description: =YCI("SAGE","description")
- Sector: =YCI("SAGE","sector")
- Industry: =YCI("SAGE","industry")
- Est. Current Fiscal Year End: =YCI("SAGE","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- SAGE Tweets Stocktwits
Advertisement
